1. Introduction {#sec1}
===============

Alzheimer\'s disease (AD), the most common form of dementia, was first reported in 1906 \[[@B1]\]. In 2006, there were about 26.6 million AD patients worldwide and it was also common in southern Taiwan \[[@B2]\]. Although AD has been identified for a long time, most research progress was made in the recent 30 years \[[@B3]\]. However, no definitive cure is available for this disease and eventually it leads to death. Therefore, the drug discovery for Alzheimer\'s disease remains challenging.

Single nucleotide polymorphisms (SNPs) are the most common variation in human genomes \[[@B4]\]. The importance of SNPs has been reviewed in genome-wide association studies for its association with disease susceptibility and drug metabolism \[[@B5], [@B6]\]. About 60--90% of the individual variation of drug response depends on pharmacogenomic factors. Therefore, SNP genotyping for candidate genes, pharmacological research, and drug discovery may play an increasingly important role in AD treatment. Meanwhile, increasing amounts of related information require the assistance of bioinformatics to construct the suitable databases and web servers.

Recently, PharmGKB (the Pharmacogenetics and Pharmacogenomics Knowledge Base) has been constructed to provide a comprehensive database for pharmacogenomic studies \[[@B7]\]. PharmGKB provides the pharmacogenetics research network in terms of SNP discovery and drug responses \[[@B8]\] with the fully curated knowledge for drug pathways, drug-related genes, and relationships among genes, drugs, and diseases. However, some information of different functions of PharmGKB is insufficient to allow convenient crosstalking between each other.

To solve this problem, we propose data mining method to improve the searching of pharmacogenomics of AD based on the download dataset of the PharmGKB resource.

2. Materials and Methods {#sec2}
========================

The flowchart for pharmacogenomics in AD for personalized drug studies is shown in [Figure 1](#fig1){ref-type="fig"}. First of all, the AD-related drugs and genes are retrieved from PharmGKB download data using approximate string matching method and data mining approach. The genes associated with AD and the genes associated with a single Alzheimer\'s drug are identified and compared with the online searching of PharmGKB. Then, numerous SNPs of genes associated with AD are identified. Through some SNP genotyping tools or assays, the association studies to AD-related drugs may be evaluated. Finally, the relevant information may be helpful for the personalized drug research.

2.1. AD-Related Drugs Using Approximate String Matching Based on PharmGKB Download Data {#sec2.1}
---------------------------------------------------------------------------------------

In order to study the pharmacogenomics of AD, we downloaded the known PharmGKB (the Pharmacogenetics and Pharmacogenomics Knowledge Base) (<http://www.pharmgkb.org/downloads/>) \[[@B10], [@B11]\] as source by the approximate string matching method \[[@B12]\] to find out all AD-related drug classes. The meaningful keywords associated with "Alzheimer\'s disease" are shown in [Table 1](#tab1){ref-type="table"}. Then, these found drug classes are used to find out associated genes by data mining approach. The description of the approximate string matching method for all AD-related drug classes gives a pattern string *P* = *p* ~1~ *p* ~2~ *p* ~3~ ⋯ *p* ~*m*~, that is, the meaningful keywords associated with "Alzheimer\'s disease" and a text string *T* = *t* ~1~ *t* ~2~ *t* ~3~ ⋯ *t* ~*n*~, that is, the description for drug and disease retrieved from PharmGKB. Find a substring *T* ~*i*,*j*~ = *t* ~*i*~ *t* ~*i*+1~ *t* ~*i*+2~ ⋯ *t* ~*j*~ in *T* that has the smallest edit distance \[[@B13]\] to the pattern *P*. The pseudocode for the edit distance is shown in [Algorithm 1](#alg1){ref-type="fig"}.

2.2. Data Mining Method for PharmGKB Download Data {#sec2.2}
--------------------------------------------------

In this study, we used a priori algorithm \[[@B14]\] for frequent item set mining and association rule learning over PharmGKB. The pseudocode for the a priori algorithm for data mining in PharmGKB is shown in [Algorithm 2](#alg2){ref-type="fig"}. At first, a priori algorithm has to find out the frequent gene in drug class for "Alzheimer\'s disease." A set of genes can be mined from each drug class. A priori algorithm is a "bottom up" approach, where frequent gene subsets are extended one item at a time (i.e., candidate generation) and groups of candidates are tested against the data. This algorithm is terminated when no further successful extensions are found.

2.3. SNP Searching for Genes Using the NCBI dbSNP {#sec2.3}
-------------------------------------------------

Every gene contains numerous SNPs. In order to find out SNPs of single gene for Alzheimer\'s pharmacogenomics, NCBI dbSNP (<http://www.ncbi.nlm.nih.gov/snp>) is used to search in the study.

3. Results and Discussion {#sec3}
=========================

3.1. AD Information Based on PharmGKB Search {#sec3.1}
--------------------------------------------

In PharmGKB online searching, the SNP variants, related genes, and drugs for AD are able to be retrieved. For example, the SNP information such as rs2066853 and rs6313 is provided ([Figure 2](#fig2){ref-type="fig"}). As shown in [Figure 3](#fig3){ref-type="fig"}, the AD-related genes such as ADRB1, AHR, HTR2A, MTHFR, and PTGS2 are identified and the related drugs such as olanzapine and risperidone are searched. This information may assist the researchers to study the pharmacogenomics of AD. Unfortunately, this PharmGKB online searching just provides limited information and it insufficiently copes with the complexity of the drug researches for Alzheimer\'s personalized medicine.

3.2. PharmGKB-Based Data Mining of AD Information of Drug Classes or Gene Symbols {#sec3.2}
---------------------------------------------------------------------------------

In current study, our proposed method is used to perform data mining for PharmGKB download data in terms of the keyword "Alzheimer\'s disease." As shown in [Table 2](#tab2){ref-type="table"}, 22 kinds of AD-related drug classes are identified from "drug classes" of PharmGKB. Their corresponding PharmGKB accession ID, PubMed PMID, and the number of genes that are associated with AD-related drug classes are also presented. In total, 495 genes are identified for AD information of drug classes (see Supplementary file 1: gene information includes PharmGKB Accession Id, gene symbol, and publications are providing in different classes; it is available online at <http://dx.doi.org/10.1155/2014/897653>). Alternatively, 99 genes associated with AD are identified from "gene symbols" of PharmGKB in terms of the keyword "Alzheimer\'s disease." These results suggest that the same keyword, for example, Alzheimer\'s disease, may identify different numbers of AD-associated genes between "drug classes" or "gene symbols" of PharmGKB.

After detailed examination, 67 genes in the gene symbols searching (bold fonts of gene names as shown in [Table 3](#tab3){ref-type="table"}) are absent from the genes in the drug class searching ([Table 2](#tab2){ref-type="table"}). Furthermore, genes corresponding to the drug "memantine" listed in [Table 2](#tab2){ref-type="table"} (drug classes) are not found in [Table 3](#tab3){ref-type="table"} (gene symbols). Therefore, some current drugs have identified a small number of AD-related genes in the drug class searching; however, the remaining AD-related genes that may affect AD-related drugs may be partly discovered in the gene symbols searching. These novelly identified AD-related genes may be the potential candidates for further drug development of AD. These results demonstrated that our proposed data mining method may be an improved AD pharmacogenomics study.

3.3. SNP Information of AD-Related Genes {#sec3.3}
----------------------------------------

The SNP statuses for 99 AD-related genes are also provided in [Table 3](#tab3){ref-type="table"}. This SNP status for each gene is calculated from the online NCBI dbSNP queries. In general, many SNPs are found in these AD-related genes. Some SNPs of these genes have been reported to be associated with AD. For example, the APOE gene is found in [Table 3](#tab3){ref-type="table"} and one of its SNPs, such as ApoE epsilon 4 allele, has been reported to be associated with AD \[[@B15]\]. With suitable tools for SNP genotyping, these SNP candidates are warranted for the pharmacogenomics research of AD.

Currently, there are many high throughput SNP genotyping methods developed (as shown in [Figure 1](#fig1){ref-type="fig"}), including PCR resequencing \[[@B16]\], TaqMan probes \[[@B17]\], SNP microarrays \[[@B18]\], Matrix Assisted Laser Desorption/Ionization-Time of Flight (MALDI-TOF) \[[@B19]\], and others \[[@B20], [@B21]\]. Furthermore, some SNP genotyping tools or databases are also developed, such as SNP-RFLPing2 for comprehensive PCR-RFLP information based on SNPs \[[@B22]--[@B25]\], algorithmic PCR-RFLP primer design and restriction enzymes for SNP genotyping \[[@B26], [@B27]\], and primer design for PCR-confronting two-pair primers (PCR-CTPP) \[[@B28], [@B29]\]. These tools and methods can provide useful and convenient information for SNP genotyping in the AD pharmacogenomics studies.

4. Conclusions {#sec4}
==============

AD is the most common form of dementia for older people. The pharmacogenomics of AD still remains a challenge. In this study, we propose the pharmGKB-based data mining method to improve the gene discoveries for the potential AD-related drug candidates. With the assistance of bioinformatics, this improvement can help researchers to develop personal therapeutic drugs of AD.
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![The flowchart for PharmGKB-based pharmacogenomics of AD in this study.](BMRI2014-897653.001){#fig1}

![PharmGKB-pharmacogenomics online query for the variant information (SNP rs\#ID) of "Alzheimer\'s disease." Retrieval source: <http://www.pharmgkb.org/disease/PA443319?previousQuery=Alzheimer's%20disease>.](BMRI2014-897653.002){#fig2}

![Gene and drug related information of "Alzheimer\'s disease" online query from PharmGKB. Retrieval source: [http://www.pharmgkb.org/disease/PA443319?previousQuery=Alzheimer\'s%20disease\#tabview=table 3&subtab=33](http://www.pharmgkb.org/disease/PA443319?previousQuery=Alzheimer's%20disease#tabview=table3&subtab=33).](BMRI2014-897653.003){#fig3}

![Pseudocode for the edit distance used for approximate string matching.](BMRI2014-897653.alg.001){#alg1}

![Pseudocode for a priori algorithm for the data mining in PharmGKB, where ε is a support threshold, *L* is the frequent gene subsets that satisfy the support threshold, *k* is the number of current iterations, and *C* is the candidate set, and count\[gene\] accesses a field of the data structure that represents gene candidate set.](BMRI2014-897653.alg.002){#alg2}

###### 

The meaningful keywords associated with "Alzheimer\'s disease" are retrieved from PharmGKB and they are applied to discover the drug classes\*.

  ID   Keywords
  ---- ------------------------------------------------------------
  1    AD
  2    Alzheimer\'s disease
  3    AD---Alzheimer\'s disease
  4    Acute Confusional Senile Dementia
  5    Alzheimer Dementia, Presenile
  6    Alzheimer Disease, Early Onset
  7    Alzheimer Disease, Late Onset
  8    Alzheimer Type Dementia
  9    Alzheimer Type Senile Dementia
  10   Alzheimer\'s Disease, Focal Onset
  11   Alzheimer\'s disease, NOS
  12   Dementia, Alzheimer Type
  13   Dementia, Presenile
  14   Dementia, Presenile Alzheimer
  15   Dementia, Primary Senile Degenerative
  16   Dementia, Senile
  17   Dementias, Presenile
  18   Dementias, Senile
  19   Disease, Alzheimer
  20   Disease, Alzheimer\'s
  21   Early Onset Alzheimer Disease
  22   Focal Onset Alzheimer\'s Disease
  23   Late Onset Alzheimer Disease
  24   Presenile Alzheimer Dementia
  25   Presenile Dementia
  26   Presenile Dementias
  27   Primary Senile Degerative Dementia
  28   Senile Dementia
  29   Senile Dementia, Acute Confusional
  30   Senile Dementia, Alzheimer Type
  31   Senile Dementias
  32   MeSH: D000544 (Alzheimer Disease)
  33   MedDRA: 10001896 (Alzheimer\'s disease)
  34   NDFRT: N0000000363 (Alzheimer Disease \[Disease/Finding\])
  35   SnoMedCT: 26929004 (Alzheimer\'s disease)
  36   UMLS: C0002395 (C0002395)

\*Drug class is one of the functions listed in the ParamGKB download data.

###### 

PharmGKB-based data mining results in terms of the PharmGKB accession ID, drug class, publications, and the number of gene information of Alzheimer\'s disease.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  No.   PharmGKB accession ID                                                           Drug classes                                                Publications^∗1^                                                                                                                                                                                                                                Gene no.^∗2^
  ----- ------------------------------------------------------------------------------- ----------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------
  1     [PA164712423](http://www.pharmgkb.org/do/serve?objId=PA164712423&objCls=Drug)   Anticholinesterases                                         PMID: [20644562](http://www.ncbi.nlm.nih.gov/pubmed/20644562)   [20644562](http://www.ncbi.nlm.nih.gov/pubmed/20644562)   [14674789](http://www.ncbi.nlm.nih.gov/pubmed/14674789)                                                               6

  2     [PA164712308](http://www.pharmgkb.org/do/serve?objId=PA164712308&objCls=Drug)   Ace inhibitors, plain                                       PMID: [17362841](http://www.ncbi.nlm.nih.gov/pubmed/17362841)                                                                                                                                                                                   24

  3     [PA449515](http://www.pharmgkb.org/do/serve?objId=PA449515&objCls=Drug)         Etanercept                                                  PMID: [19027875](http://www.ncbi.nlm.nih.gov/pubmed/19027875)                                                                                                                                                                                   12

  4     [PA451262](http://www.pharmgkb.org/do/serve?objId=PA451262&objCls=Drug)         Rivastigmine                                                PMID: [20644562](http://www.ncbi.nlm.nih.gov/pubmed/20644562)   [16323253](http://www.ncbi.nlm.nih.gov/pubmed/16323253)   [17082448](http://www.ncbi.nlm.nih.gov/pubmed/17082448) \                                                             2
                                                                                                                                                    [20644562](http://www.ncbi.nlm.nih.gov/pubmed/20644562)   [15289797](http://www.ncbi.nlm.nih.gov/pubmed/15289797)   [17522596](http://www.ncbi.nlm.nih.gov/pubmed/17522596)                                                                     

  5     [PA450243](http://www.pharmgkb.org/do/serve?objId=PA450243&objCls=Drug)         Lithium                                                     PMID: [17082448](http://www.ncbi.nlm.nih.gov/pubmed/17082448)                                                                                                                                                                                   13

  6     [PA10384](http://www.pharmgkb.org/do/serve?objId=PA10384&objCls=Drug)           Anti-inflammatory and antirheumatic products, nonsteroids   PMID: [17082448](http://www.ncbi.nlm.nih.gov/pubmed/17082448)   [17082448](http://www.ncbi.nlm.nih.gov/pubmed/17082448)                                                                                                                         11

  7     [PA449760](http://www.pharmgkb.org/do/serve?objId=PA449760&objCls=Drug)         Glatiramer acetate                                          PMID: [17082448](http://www.ncbi.nlm.nih.gov/pubmed/17082448)                                                                                                                                                                                   4

  8     [PA133950441](http://www.pharmgkb.org/do/serve?objId=PA133950441&objCls=Drug)   Hmg coa reductase inhibitors                                PMID: [17082448](http://www.ncbi.nlm.nih.gov/pubmed/17082448)                                                                                                                                                                                   39

  9     [PA151958596](http://www.pharmgkb.org/do/serve?objId=PA151958596&objCls=Drug)   Curcumin                                                    PMID: [17082448](http://www.ncbi.nlm.nih.gov/pubmed/17082448)                                                                                                                                                                                   2

  10    [PA451898](http://www.pharmgkb.org/do/serve?objId=PA451898&objCls=Drug)         Vitamin c                                                   PMID: [17082448](http://www.ncbi.nlm.nih.gov/pubmed/17082448)                                                                                                                                                                                   16

  11    [PA451900](http://www.pharmgkb.org/do/serve?objId=PA451900&objCls=Drug)         Vitamin e                                                   PMID: [17082448](http://www.ncbi.nlm.nih.gov/pubmed/17082448)                                                                                                                                                                                   1

  12    [PA452229](http://www.pharmgkb.org/do/serve?objId=PA452229&objCls=Drug)         Antidepressants                                             PMID: [17082448](http://www.ncbi.nlm.nih.gov/pubmed/17082448)                                                                                                                                                                                   43

  13    [PA452233](http://www.pharmgkb.org/do/serve?objId=PA452233&objCls=Drug)         Antipsychotics                                              PMID: [17082448](http://www.ncbi.nlm.nih.gov/pubmed/17082448)                                                                                                                                                                                   46

  14    [PA449726](http://www.pharmgkb.org/do/serve?objId=PA449726&objCls=Drug)         Galantamine                                                 PMID: [20644562](http://www.ncbi.nlm.nih.gov/pubmed/20644562)   [16323253](http://www.ncbi.nlm.nih.gov/pubmed/16323253)   [17082448](http://www.ncbi.nlm.nih.gov/pubmed/17082448) \                                                             7
                                                                                                                                                    [15853556](http://www.ncbi.nlm.nih.gov/pubmed/15853556)   [20644562](http://www.ncbi.nlm.nih.gov/pubmed/20644562)   [14674789](http://www.ncbi.nlm.nih.gov/pubmed/14674789)   [12177686](http://www.ncbi.nlm.nih.gov/pubmed/12177686)           

  15    [PA10364](http://www.pharmgkb.org/do/serve?objId=PA10364&objCls=Drug)           Memantine                                                   PMID: [17082448](http://www.ncbi.nlm.nih.gov/pubmed/17082448)                                                                                                                                                                                   0

  16    [PA451283](http://www.pharmgkb.org/do/serve?objId=PA451283&objCls=Drug)         Rosiglitazone                                               PMID: [16770341](http://www.ncbi.nlm.nih.gov/pubmed/16770341)                                                                                                                                                                                   34

  17    [PA448031](http://www.pharmgkb.org/do/serve?objId=PA448031&objCls=Drug)         Acetylcholine                                               PMID: [15695160](http://www.ncbi.nlm.nih.gov/pubmed/15695160)                                                                                                                                                                                   8

  18    [PA450626](http://www.pharmgkb.org/do/serve?objId=PA450626&objCls=Drug)         Nicotine                                                    PMID: [15695160](http://www.ncbi.nlm.nih.gov/pubmed/15695160)                                                                                                                                                                                   88

  19    [PA137179528](http://www.pharmgkb.org/do/serve?objId=PA137179528&objCls=Drug)   Nimesulide                                                  PMID: [16331303](http://www.ncbi.nlm.nih.gov/pubmed/16331303)   [11810182](http://www.ncbi.nlm.nih.gov/pubmed/11810182)                                                                                                                         3

  20    [PA449394](http://www.pharmgkb.org/do/serve?objId=PA449394&objCls=Drug)         Donepezil                                                   PMID: [20859244](http://www.ncbi.nlm.nih.gov/pubmed/20859244)   [20644562](http://www.ncbi.nlm.nih.gov/pubmed/20644562)   [16323253](http://www.ncbi.nlm.nih.gov/pubmed/16323253) \                                                             9
                                                                                                                                                    [16424819](http://www.ncbi.nlm.nih.gov/pubmed/16424819)   [17082448](http://www.ncbi.nlm.nih.gov/pubmed/17082448)   [20644562](http://www.ncbi.nlm.nih.gov/pubmed/20644562)   [1973817012142731](http://www.ncbi.nlm.nih.gov/pubmed/19738170)   

  21    [PA451576](http://www.pharmgkb.org/do/serve?objId=PA451576&objCls=Drug)         Tacrine                                                     PMID: [9521254](http://www.ncbi.nlm.nih.gov/pubmed/9521254)   [17082448](http://www.ncbi.nlm.nih.gov/pubmed/17082448)   [10801254](http://www.ncbi.nlm.nih.gov/pubmed/10801254) \                                                               6
                                                                                                                                                    [9777427](http://www.ncbi.nlm.nih.gov/pubmed/9777427)   [18004213](http://www.ncbi.nlm.nih.gov/pubmed/18004213)                                                                                                                                 

  22    [PA448976](http://www.pharmgkb.org/do/serve?objId=PA448976&objCls=Drug)         Choline                                                     PMID: [8618881](http://www.ncbi.nlm.nih.gov/pubmed/8618881)                                                                                                                                                                                     122
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^∗1^PMID: PubMed article ID number.

^∗2^The full gene names for each of the "drug classes" have been provided in the Supplementary file 1.

###### 

PharmGKB-based data mining results of gene symbols of Alzheimer\'s disease and NCBI dbSNP-based query results for SNP number for the genes of Alzheimer\'s disease.

  No.   PharmGKB accession ID                                                           Gene symbols\*   SNP no.   No.   PharmGKB accession ID                                                           Gene symbols\*   SNP no.   No.   PharmGKB accession ID                                                           Gene symbols\*   SNP no.
  ----- ------------------------------------------------------------------------------- ---------------- --------- ----- ------------------------------------------------------------------------------- ---------------- --------- ----- ------------------------------------------------------------------------------- ---------------- ---------
  1     [PA20](http://www.pharmgkb.org/do/serve?objId=PA20&objCls=Gene)                 ACHE             899       34    [PA37597](http://www.pharmgkb.org/do/serve?objId=PA37597&objCls=Gene)           **ZNF225**       813       67    [PA125](http://www.pharmgkb.org/do/serve?objId=PA125&objCls=Gene)               CYP2C8           993
  2     [PA26490](http://www.pharmgkb.org/do/serve?objId=PA26490&objCls=Gene)           CHRNA4           1518      35    [PA38499](http://www.pharmgkb.org/do/serve?objId=PA38499&objCls=Gene)           **DEFB123**      330       68    [PA126](http://www.pharmgkb.org/do/serve?objId=PA126&objCls=Gene)               CYP2C9           1605
  3     [PA128](http://www.pharmgkb.org/do/serve?objId=PA128&objCls=Gene)               CYP2D6           482       36    [PA134902026](http://www.pharmgkb.org/do/serve?objId=PA134902026&objCls=Gene)   **SORCS2**       19073     69    [PA30864](http://www.pharmgkb.org/do/serve?objId=PA30864&objCls=Gene)           MME              3323
  4     [PA130](http://www.pharmgkb.org/do/serve?objId=PA130&objCls=Gene)               CYP3A4           899       37    [PA134949387](http://www.pharmgkb.org/do/serve?objId=PA134949387&objCls=Gene)   **SORCS3**       13969     70    [PA142671271](http://www.pharmgkb.org/do/serve?objId=PA142671271&objCls=Gene)   **NCSTN**        741
  5     [PA26620](http://www.pharmgkb.org/do/serve?objId=PA26620&objCls=Gene)           **CLU**          644       38    [PA38274](http://www.pharmgkb.org/do/serve?objId=PA38274&objCls=Gene)           **TOMM40**       462       71    [PA36153](http://www.pharmgkb.org/do/serve?objId=PA36153&objCls=Gene)           **SST**          120
  6     [PA26855](http://www.pharmgkb.org/do/serve?objId=PA26855&objCls=Gene)           **CR1**          19859     39    [PA162397694](http://www.pharmgkb.org/do/serve?objId=PA162397694&objCls=Gene)   **NLRC5**        2297      72    [PA36457](http://www.pharmgkb.org/do/serve?objId=PA36457&objCls=Gene)           **TF**           1501
  7     [PA33287](http://www.pharmgkb.org/do/serve?objId=PA33287&objCls=Gene)           **PICALM**       3169      40    [PA24641](http://www.pharmgkb.org/do/serve?objId=PA24641&objCls=Gene)           **AHR**          991       73    [PA31930](http://www.pharmgkb.org/do/serve?objId=PA31930&objCls=Gene)           OPCML            28437
  8     [PA46](http://www.pharmgkb.org/do/serve?objId=PA46&objCls=Gene)                 **ALOX5**        1992      41    [PA134950706](http://www.pharmgkb.org/do/serve?objId=PA134950706&objCls=Gene)   **DNMBP**        3312      74    [PA29561](http://www.pharmgkb.org/do/serve?objId=PA29561&objCls=Gene)           **HTR7**         2623
  9     [PA293](http://www.pharmgkb.org/do/serve?objId=PA293&objCls=Gene)               PTGS2            579       42    [PA24910](http://www.pharmgkb.org/do/serve?objId=PA24910&objCls=Gene)           APP              9411      75    [PA162393285](http://www.pharmgkb.org/do/serve?objId=PA162393285&objCls=Gene)   **KIF20B**       2109
  10    [PA108](http://www.pharmgkb.org/do/serve?objId=PA108&objCls=Gene)               CETP             1246      43    [PA238](http://www.pharmgkb.org/do/serve?objId=PA238&objCls=Gene)               MAPT             4399      76    [PA26971](http://www.pharmgkb.org/do/serve?objId=PA26971&objCls=Gene)           **CSRP3**        907
  11    [PA32996](http://www.pharmgkb.org/do/serve?objId=PA32996&objCls=Gene)           **PCDH11X**      15199     44    [PA128394579](http://www.pharmgkb.org/do/serve?objId=PA128394579&objCls=Gene)   TMED10           1079      77    [PA231](http://www.pharmgkb.org/do/serve?objId=PA231&objCls=Gene)               **LMNA**         1486
  12    [PA24507](http://www.pharmgkb.org/do/serve?objId=PA24507&objCls=Gene)           **ADAM12**       10827     45    [PA162397475](http://www.pharmgkb.org/do/serve?objId=PA162397475&objCls=Gene)   **NGF**          1286      78    [PA27029](http://www.pharmgkb.org/do/serve?objId=PA27029&objCls=Gene)           **CTSD**         460
  13    [PA25165](http://www.pharmgkb.org/do/serve?objId=PA25165&objCls=Gene)           **ATP8A1**       5983      46    [PA25232](http://www.pharmgkb.org/do/serve?objId=PA25232&objCls=Gene)           **BACE1**        794       79    [PA29629](http://www.pharmgkb.org/do/serve?objId=PA29629&objCls=Gene)           **IDE**          2755
  14    [PA26243](http://www.pharmgkb.org/do/serve?objId=PA26243&objCls=Gene)           **CD86**         1385      47    [PA36022](http://www.pharmgkb.org/do/serve?objId=PA36022&objCls=Gene)           **SORL1**        4394      80    [PA31374](http://www.pharmgkb.org/do/serve?objId=PA31374&objCls=Gene)           **MYH7**         1157
  15    [PA26935](http://www.pharmgkb.org/do/serve?objId=PA26935&objCls=Gene)           **CSF1**         569       48    [PA33796](http://www.pharmgkb.org/do/serve?objId=PA33796&objCls=Gene)           **PRNP**         452       81    [PA272](http://www.pharmgkb.org/do/serve?objId=PA272&objCls=Gene)               **PLN**          343
  16    [PA27342](http://www.pharmgkb.org/do/serve?objId=PA27342&objCls=Gene)           **DISC1**        11813     49    [PA37302](http://www.pharmgkb.org/do/serve?objId=PA37302&objCls=Gene)           **VEGFA**        561       82    [PA33855](http://www.pharmgkb.org/do/serve?objId=PA33855&objCls=Gene)           **PSEN1**        2343
  17    [PA28597](http://www.pharmgkb.org/do/serve?objId=PA28597&objCls=Gene)           **GBP2**         625       50    [PA114](http://www.pharmgkb.org/do/serve?objId=PA114&objCls=Gene)               CHRNA7           3714      83    [PA33856](http://www.pharmgkb.org/do/serve?objId=PA33856&objCls=Gene)           **PSEN2**        959
  18    [PA220](http://www.pharmgkb.org/do/serve?objId=PA220&objCls=Gene)               **KCNMA1**       19081     51    [PA37155](http://www.pharmgkb.org/do/serve?objId=PA37155&objCls=Gene)           **UBQLN1**       1400      84    [PA304](http://www.pharmgkb.org/do/serve?objId=PA304&objCls=Gene)               SCN5A            3380
  19    [PA25512](http://www.pharmgkb.org/do/serve?objId=PA25512&objCls=Gene)           **KCTD12**       235       52    [PA26123](http://www.pharmgkb.org/do/serve?objId=PA26123&objCls=Gene)           **CBS**          924       85    [PA36638](http://www.pharmgkb.org/do/serve?objId=PA36638&objCls=Gene)           TNNT2            739
  20    [PA164724093](http://www.pharmgkb.org/do/serve?objId=PA164724093&objCls=Gene)   NOS2             1820      53    [PA26976](http://www.pharmgkb.org/do/serve?objId=PA26976&objCls=Gene)           **CST3**         233       86    [PA139](http://www.pharmgkb.org/do/serve?objId=PA139&objCls=Gene)               ACE              1108
  21    [PA33614](http://www.pharmgkb.org/do/serve?objId=PA33614&objCls=Gene)           **PPP1R11**      215       54    [PA25623](http://www.pharmgkb.org/do/serve?objId=PA25623&objCls=Gene)           C1QB             356       87    [PA37935](http://www.pharmgkb.org/do/serve?objId=PA37935&objCls=Gene)           **SIRT1**        1145
  22    [PA143485670](http://www.pharmgkb.org/do/serve?objId=PA143485670&objCls=Gene)   **WWC1**         5070      55    [PA162380954](http://www.pharmgkb.org/do/serve?objId=PA162380954&objCls=Gene)   **CALHM1**       247       88    [PA55](http://www.pharmgkb.org/do/serve?objId=PA55&objCls=Gene)                 APOE             184
  23    [PA37596](http://www.pharmgkb.org/do/serve?objId=PA37596&objCls=Gene)           **ZNF224**       490       56    [PA30748](http://www.pharmgkb.org/do/serve?objId=PA30748&objCls=Gene)           **MEOX2**        2140      89    [PA24357](http://www.pharmgkb.org/do/serve?objId=PA24357&objCls=Gene)           **A2M**          1385
  24    [PA162380963](http://www.pharmgkb.org/do/serve?objId=PA162380963&objCls=Gene)   **CALHM2**       192       57    [PA26448](http://www.pharmgkb.org/do/serve?objId=PA26448&objCls=Gene)           CHAT             2572      90    [PA192](http://www.pharmgkb.org/do/serve?objId=PA192&objCls=Gene)               HTR1A            186
  25    [PA51](http://www.pharmgkb.org/do/serve?objId=PA51&objCls=Gene)                 APOC1            243       58    [PA38239](http://www.pharmgkb.org/do/serve?objId=PA38239&objCls=Gene)           **CLSTN2**       15608     91    [PA182](http://www.pharmgkb.org/do/serve?objId=PA182&objCls=Gene)               GSTM1            264
  26    [PA34958](http://www.pharmgkb.org/do/serve?objId=PA34958&objCls=Gene)           **ATXN1**        11910     59    [PA134952303](http://www.pharmgkb.org/do/serve?objId=PA134952303&objCls=Gene)   **NMNAT3**       39        92    [PA183](http://www.pharmgkb.org/do/serve?objId=PA183&objCls=Gene)               GSTT1            200
  27    [PA26210](http://www.pharmgkb.org/do/serve?objId=PA26210&objCls=Gene)           **CD33**         465       60    [PA134904440](http://www.pharmgkb.org/do/serve?objId=PA134904440&objCls=Gene)   **C1orf49**      348       93    [PA268](http://www.pharmgkb.org/do/serve?objId=PA268&objCls=Gene)               ABCB4            1915
  28    [PA28478](http://www.pharmgkb.org/do/serve?objId=PA28478&objCls=Gene)           **GAB2**         5119      61    [PA134864387](http://www.pharmgkb.org/do/serve?objId=PA134864387&objCls=Gene)   **RALGPS2**      3980      94    [PA115](http://www.pharmgkb.org/do/serve?objId=PA115&objCls=Gene)               CHRNB2           698
  29    [PA34052](http://www.pharmgkb.org/do/serve?objId=PA34052&objCls=Gene)           **PVRL2**        1344      62    [PA134870196](http://www.pharmgkb.org/do/serve?objId=PA134870196&objCls=Gene)   **RGSL1**        3300      95    [PA156](http://www.pharmgkb.org/do/serve?objId=PA156&objCls=Gene)               **ESR1**         10108
  30    [PA37754](http://www.pharmgkb.org/do/serve?objId=PA37754&objCls=Gene)           **ZNRD1**        316       63    [PA25294](http://www.pharmgkb.org/do/serve?objId=PA25294&objCls=Gene)           BCHE             1796      96    [PA134934259](http://www.pharmgkb.org/do/serve?objId=PA134934259&objCls=Gene)   **GAPDHS**       361
  31    [PA38114](http://www.pharmgkb.org/do/serve?objId=PA38114&objCls=Gene)           **TRIM15**       466       64    [PA120](http://www.pharmgkb.org/do/serve?objId=PA120&objCls=Gene)               CRP              977       97    [PA245](http://www.pharmgkb.org/do/serve?objId=PA245&objCls=Gene)               MTHFR            790
  32    [PA134927803](http://www.pharmgkb.org/do/serve?objId=PA134927803&objCls=Gene)   **MTHFD1L**      7229      65    [PA127](http://www.pharmgkb.org/do/serve?objId=PA127&objCls=Gene)               **CYP2C18**      1353      98    [PA36458](http://www.pharmgkb.org/do/serve?objId=PA36458&objCls=Gene)           **TFAM**         376
  33    [PA144596420](http://www.pharmgkb.org/do/serve?objId=PA144596420&objCls=Gene)   **INTS1**        1820      66    [PA124](http://www.pharmgkb.org/do/serve?objId=PA124&objCls=Gene)               CYP2C19          2692      99    [PA435](http://www.pharmgkb.org/do/serve?objId=PA435&objCls=Gene)               TNF              268

\*Gene names in bold fonts are not identified in [Table 2](#tab2){ref-type="table"}.

[^1]: Academic Editor: Wei Chiao Chang
